Adma Biologics reported $135.86M in Trade Debtors for its fiscal quarter ending in March of 2026.





Trade Debtors Change Date
Adma Biologics USD 135.86M 22.57M Mar/2026
Alnylam Pharmaceuticals USD 912.74M 28.78M Jun/2026
BioCryst Pharmaceuticals USD 110.76M 3.94M Jun/2026
Novavax USD 106.45M 72.27M Dec/2025
Omeros USD 8.08M 440K Jun/2024
Takeda JPY 956.14B 79.79B Jun/2026